Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Larotrectinib | 1223403-58-4 | 99.9% | 50 MG
Supplier: Medchemexpress LLC HY1286650MG
Larotrectinib (LOXO-101) is an ATP-competitive oral, selective inhibitor of the tropomyosin-related kinase (TRK) family receptors, demonstrating low nanomolar 50% inhibitory concentrations against all three isoforms (TRKA, B, and C). This product is intended for research and analytical applications.
- Selective inhibitor of TRK family receptors
- ATP-competitive mechanism of action
- Inhibits TRKA, B, and C isoforms
- Exhibits antiproliferative activity against various TRK fusion and mutant cell lines
- For research use only
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?